looks to me that this is the third orchestrated attack on the share price during the past few months ... nothing to do with fundamentalsthe motives of the those doing this are certainly mysterious - possibly some sort of bear raid
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
